Trial Profile
Study of half-dose photodynamic therapy combined with intravitreal bevacizumab in patients with polypoidal choroidal vasculopathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Polypoidal choroidal vasculopathy
- Focus Therapeutic Use
- 26 Feb 2016 New trial record